---
title: "Aethlon Medical Q2 2026 Earnings Preview"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/265404869.md"
description: "Aethlon Medical (AEMD) will announce its Q2 earnings on November 12th, post-market. The consensus EPS estimate is -$1.70, reflecting a 750% year-over-year decline. Historically, AEMD has met EPS estimates 50% of the time and revenue estimates 13% of the time. In the past three months, there have been two upward revisions to EPS estimates."
datetime: "2025-11-11T22:46:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265404869.md)
  - [en](https://longbridge.com/en/news/265404869.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265404869.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/265404869.md) | [繁體中文](https://longbridge.com/zh-HK/news/265404869.md)


# Aethlon Medical Q2 2026 Earnings Preview

Aethlon Medical (AEMD) is scheduled to announce Q2 earnings results on Wednesday, November 12th, after market close.The consensus EPS Estimate is -$1.70 (-750.0% Y/Y) Over the last 2 years, AEMD has beaten EPS estimates 50% of the time and has beaten revenue estimates 13% of the time.Over the last 3 months, EPS estimates have seen 2 upward revisions...

### Related Stocks

- [Aethlon Medical, Inc. (AEMD.US)](https://longbridge.com/en/quote/AEMD.US.md)

## Related News & Research

- [Aethlon Medical Inc. Announces Date for Upcoming Annual Stockholder Meeting](https://longbridge.com/en/news/272878702.md)
- [Electra Battery Materials GAAP EPS of -C$4.16](https://longbridge.com/en/news/280982421.md)
- [TeraGo GAAP EPS of -$0.20, revenue of $6.2M](https://longbridge.com/en/news/281028086.md)
- [ZyVersa Therapeutics GAAP EPS of -$4.18](https://longbridge.com/en/news/281255183.md)
- [Spire Refines Strategy with Marketing Exit, EPS Update](https://longbridge.com/en/news/281017540.md)